Who are LOVAZA Omega 3-acid ethyl esters's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Omega-3 fatty acid capsules, Product 3 - Standard Fish Oil Triglyceride, Product 2 - AquaCelle Fish Oil Ethyl Ester, THYROX (Atlantic krill oil)..

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/lovaza-omega-3-acid-ethyl-esters.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

LOVAZA Omega 3-acid ethyl esters — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LOVAZA Omega 3-acid ethyl esters (LOVAZA Omega 3-acid ethyl esters) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Omega-3 fatty acid supplement. Area: Cardiovascular.

marketed Omega-3 fatty acid supplement Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

LOVAZA Omega 3-acid ethyl esters (LOVAZA Omega 3-acid ethyl esters) — University of Michigan. LOVAZA reduces triglyceride levels by providing omega-3 fatty acids (EPA and DHA) that decrease hepatic triglyceride synthesis and increase triglyceride clearance.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
LOVAZA Omega 3-acid ethyl esters TARGET	LOVAZA Omega 3-acid ethyl esters	University of Michigan	marketed	Omega-3 fatty acid supplement
Omega-3 fatty acid capsules	Omega-3 fatty acid capsules	Medical Center Alkmaar	marketed	Omega-3 fatty acid supplement
Product 3 - Standard Fish Oil Triglyceride	Product 3 - Standard Fish Oil Triglyceride	RDC Clinical Pty Ltd	marketed	Omega-3 fatty acid supplement
Product 2 - AquaCelle Fish Oil Ethyl Ester	Product 2 - AquaCelle Fish Oil Ethyl Ester	RDC Clinical Pty Ltd	marketed	Omega-3 fatty acid supplement / Triglyceride-lowering agent	Multiple targets including PPAR-alpha, GPR120, and hepatic lipid metabolism pathways
THYROX (Atlantic krill oil).	THYROX (Atlantic krill oil).	Poznan University of Physical Education	marketed	Dietary supplement / Omega-3 fatty acid supplement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Omega-3 fatty acid supplement class)

Medical Center Alkmaar · 1 drug in this class
RDC Clinical Pty Ltd · 1 drug in this class
University of Michigan · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). LOVAZA Omega 3-acid ethyl esters — Competitive Intelligence Brief. https://druglandscape.com/ci/lovaza-omega-3-acid-ethyl-esters. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab